Concerning the lawful use of a prescription drug that contains 3,4-methylenedioxymethamphetamine (MDMA) that is approved by the United States food and drug administration.
04/29/2022 | Senate Third Reading Passed - No Amendments
Concerning changes to medicaid to allow for expedited repairs to complex rehabilitation technology, and, in connection therewith, making an appropriation.
05/5/2022 | Senate Third Reading Passed - No Amendments
Concerning the continuation of the regulation of conveyances, and, in connection therewith, implementing the recommendations contained in the 2021 sunset report by the department of regulatory agencies.
04/28/2022 | Senate Third Reading Passed - No Amendments